Zydus Cadila has announced that the US health regulator has given final approval to market generic Abacavir and Lamivudine tablets, which are primarily used for...
Drug firm Zydus Cadila has said that it has received final nod from the United States Food and Drug Administration (USFDA) to market generic Desoximetasone...
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
Zydus Cadila has signed an agreement with Council of Scientific and Industrial Research (CSIR) – Institute of Microbial Technology (IMTECH), to identify new drug candidates...
Zydus Cadila receives final approval to market Nystatin ointment and Omeprazoleand Sodium Bicarbonate capsule, from the US health regulator. The company received approval to market Nystatin Ointment USP,...
Zydus Cadila has received final approval to market two drugs, from the US health regulator. The company stated that, it has received approval to market Methylprednisolone tablets USP...
Zydus Cadila, has received final approval from US health regulator to market Dexmedetomidine Hydrochloride injection. The company in a regulatory filing stated that, the approval is...
Zydus Cadila has received final approval to market topiramate extended release capsules, from the US health regulator. It is used for treating seizures and migraine. In...